What are the normal total and free testosterone levels for a healthy 34-year-old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Testosterone Levels in a 34-Year-Old Woman

For a healthy 34-year-old woman, normal total testosterone ranges from approximately 15-50 ng/dL (0.52-1.73 nmol/L), with free testosterone ranging from 1.2-6.4 pg/mL (4.2-22.2 pmol/L), though these values should be measured using accurate liquid chromatography-tandem mass spectrometry methods rather than standard automated immunoassays.

Key Reference Ranges by Age and Method

The most reliable data for women in their mid-30s comes from studies using validated mass spectrometry methods:

Total Testosterone

  • Age 30-34 years: 0.35-1.97 nmol/L (approximately 10-57 ng/dL) based on the 2.5th-97.5th percentiles 1
  • Age 30-year-old reference: 15-46 ng/dL (520-1595 pmol/L) using the 5th-95th percentiles 2
  • General reproductive age women: 14.1 ± 0.9 ng/dL mean in women without hyperandrogenism, with upper limit of normal at 28 ng/dL 3

Free Testosterone

  • Age 30-year-old reference: 1.2-6.4 pg/mL (4.16-22.2 pmol/L) measured by equilibrium dialysis 2
  • Calculated free testosterone: 1.3-5.6 pg/mL (4.5-19.4 pmol/L) 2
  • Age 20-80 years range: 0.0025-0.0253 nmol/L (0.72-7.3 pg/mL) 1

Critical Considerations for Accurate Measurement

Assay Quality Matters Significantly

The single most important factor in testosterone measurement for women is using a validated assay method. Standard automated immunoassays available in most hospital laboratories are fundamentally inadequate for measuring testosterone in women 4. These assays:

  • Lack accuracy in the low concentration range typical of women
  • Have excessively broad "normal" ranges derived from populations that may include women with unrecognized androgen excess 4
  • Show systematic differences between laboratories, where the same value may be labeled normal to abnormally high depending on the lab's reference range 5

Use liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods whenever possible 4, 1. Specialty laboratories with validated assays provide more accurate determinations than commercial laboratories.

Timing of Sample Collection

Testosterone levels in women vary throughout the menstrual cycle 4, 6:

  • Highest levels: Early morning and at midcycle (ovulation)
  • Variation: Approximately 25% around the mean during the midfollicular phase 4
  • Slightly lower: Perimenstrual phase
  • Peak at midcycle: Can reach 43.6 ± 16.2 ng/dL for total testosterone 6

Optimal sampling: Early morning, follicular phase (first 7 days of menstrual cycle) provides the most standardized reference point 5. However, the overall variability across the cycle is relatively small compared to between-woman variability, so these reference ranges can generally be applied regardless of cycle day 2.

Understanding Free vs. Total Testosterone

Free testosterone is more sensitive than total testosterone for detecting androgen excess 4. This occurs because:

  • Only 1-3% of testosterone circulates unbound (free)
  • The remainder binds to sex hormone-binding globulin (SHBG) and albumin
  • SHBG levels are suppressed by androgens, hyperinsulinemia, and hypothyroidism 4
  • Women with hyperandrogenism often have relatively low SHBG, which elevates free testosterone even when total testosterone appears normal

Measurement Methods for Free Testosterone

The most reliable approaches 4:

  1. Equilibrium dialysis (gold standard)
  2. Ultrafiltration
  3. Calculated free testosterone from total testosterone and SHBG concentrations

Avoid direct immunoassays for free testosterone—these are seriously flawed and unreliable 7.

Age-Related Decline

Testosterone levels decline progressively with age 7, 1:

  • Total testosterone: Shows distinct age-related decline (P < 0.001) 1
  • Free testosterone: Declines more noticeably than total testosterone
  • At age 34: A woman is still in the higher range compared to perimenopausal and postmenopausal women
  • Postmenopausal: Most studies show no significant acute change across menopause itself, but progressive decline continues 7

Common Pitfalls to Avoid

  1. Using commercial laboratory reference ranges: These often list upper limits of 95 ng/dL or higher, which are far too broad and will miss most cases of hyperandrogenism 3

  2. Relying on total testosterone alone: Free testosterone may be elevated when total testosterone appears normal, particularly in women with low SHBG 4

  3. Not considering assay methodology: Results from different laboratories using different methods are not directly comparable 4, 5

  4. Ignoring clinical context: Women over 35 with longstanding hyperandrogenic symptoms may no longer show elevated testosterone levels as ovarian androgen production decreases with age 5

Practical Application

For a 34-year-old woman:

  • Normal total testosterone: 15-50 ng/dL (0.52-1.73 nmol/L) using validated assays
  • Normal free testosterone: 1.2-6.4 pg/mL (4.2-22.2 pmol/L)
  • Upper limit for screening: Values above 28-46 ng/dL for total testosterone warrant further evaluation 2, 3
  • Bioavailable testosterone: 1.12-7.62 ng/dL (38.8-264.21 pmol/L) 2

If evaluating for hyperandrogenism, measure both total and free testosterone using LC-MS/MS methods, ideally in the early morning during the follicular phase, and compare results to age-appropriate reference ranges established using similar methodology.

References

Research

Serum testosterone levels and reference ranges in reproductive-age women.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1999

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Guideline

androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.